Exposure-Efficacy Analyses of Nintedanib in Patients with Chronic Fibrosing Interstitial Lung Disease

Pharmacometrics

Respiratory

Respir Med. 2021 Apr;180:106369.

Schmid U, Weber B, Magnusson MO, Freiwald M